BioCentury
ARTICLE | Financial News

Acasti completes follow-on and private placement of convertible debentures and warrants

February 24, 2017 7:03 PM UTC

Hypertriglyceridemia company Acasti Pharma Inc. (TSX-V:ACST; NASDAQ:ACST) raised C$7.7 million ($5.9 million) in concurrent financings on Feb. 21. In a follow-on underwritten by Echelon Wealth Partne...

BCIQ Company Profiles

Acasti Pharma Inc.